Sassicaia Capital Advisers »

Vanda Pharmaceuticals shares owned by Sassicaia Capital Advisers

Quarter-by-quarter ownership of Vanda Pharmaceuticals (VNDA) shares owned by Sassicaia Capital Advisers from 13F filings

Historical chart of Sassicaia Capital Advisers investment in Vanda Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Vanda Pharmaceuticals held by Sassicaia Capital Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vanda Pharmaceuticals by Sassicaia Capital Advisers

Quarter filed Position value Share count Share price at filing
2025-12-31 $130k 15k 8.82

More positions owned by Sassicaia Capital Advisers

Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Spdr Gold Tr Gold Shs (GLD)
Apple (AAPL)
Warner Bros Discovery Com Ser A (WBD)
Graniteshares Etf Tr 2x Long Nvda Dai (NVDL)
JPMorgan Chase & Co. (JPM)
NVIDIA Corporation (NVDA)
Ishares Ethereum Tr SHS (ETHA)
Meta Platforms Cl A (META)
Goldman Sachs (GS)
Direxion Shs Etf Tr Dly Smcap Bull3x (TNA)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)

View all positions for Sassicaia Capital Advisers

Top funds holding Vanda Pharmaceuticals

BlackRock
Vanguard Group
Millennium Management
Renaissance Technologies
Acadian Asset Management
Dimensional Fund Advisors
AIGH Capital Management
Geode Capital Management
State Street Corporation
Krensavage Asset Management
Empire Financial Management Company
Two Sigma Advisers
Connor, Clark & Lunn Investment Management
Jacobs Levy Equity Management
AQR Capital Management

View all funds holding Vanda Pharmaceuticals